Androgen receptor co-activators in the regulation of cellular events in prostate cancer

World Journal of Urology

Volumn 30, Issue 3, 2012, Pages 297-302

  Culig, Zoran ^a   Santer, Frédéric R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Androgen receptor; Co activators; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84861624346     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0797-6     Document Type: Article

References (48)

1. Heemers H, Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28: 778-808.
2. Yeh S, Chang C (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93: 5517-5521.
3. Miyamoto H, Yeh S, Wilding G et al (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA 95: 7379-7384.
4. Miyamoto H, Yeh S, Lardy H et al (1998) Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci USA 95: 11083-11088.
5. Nessler-Menardi C, Jotova I, Culig Z et al (2000) Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models. Prostate 45: 124-131.
6. Halkidou K, Gnanapragasam VJ, Mehta PB et al (2003) Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22: 2466-2477.
7. Montogmery BT, Young CY, Bilhartz DL et al (1992) Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 21: 63-73.
8. Kyprianou N, Isaacs JT (1989) Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3: 1515-1522.
9. Heemers HV, Regan KM, Dehm SM et al (2007) Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role of serum response factor in prostate cancer. Cancer Res 67: 10592-10599.
10. Agoulnik IU, Vaid A, Nakka M et al (2006) Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 66: 10594-10602.
11. Gao T, Brantley K, Bolu E et al (1999) RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. Mol Endocrinol 13: 1645-1656.
12. Comuzzi B, Nemes C, Schmidt S et al (2004) The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer. J Pathol 204: 159-166.
13. Heemers H, Sebo TJ, Debes JD et al (2007) Androgen deprivation increases p300 expression in prostate cancer cells. Cancer Res 67: 3422-3430.
14. Shiota M, Yokomizo A, Masubuchi D et al (2010) Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. Prostate 70: 540-544.
15. Gregory CW, Fei X, Pongula LA et al (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279: 7119-7130.
16. Craft N, Shostak Y, Carey M et al (1999) A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 5: 280-285.
17. Feng S, Tang Q, Sun M et al (2009) Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. Mol Cancer Ther 8: 665-671.
18. Debes JD, Schmidt LJ, Huang H et al (2002) p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res 62: 5632-5636.
19. Culig Z, Steiner H, Bartsch G et al (2005) Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95: 497-505.
20. Malinowska K, Neuwirt H, Cavarretta IT et al (2009) Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer 16: 155-169.
21. Hobisch A, Eder IE, Putz et al (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58: 4640-4645.
22. Debes JD, Comuzzi B, Schmidt LJ et al (2005) p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6. Cancer Res 65: 5965-5973.
23. Comuzzi L, Lambrinidis L, Rogatsch H et al (2003) The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function. Am J Pathol 162: 233-241.
24. Gong J, Zhu J, Goodman OB Jr et al (2006) Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene 25: 2011-2021.
25. Agoulnik IU, Vaid A, Bingman WE 3rd et al (2005) Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65: 7959-7967.
26. Gnanapragasam VJ, Leung HY, Pullmood AS et al (2001) Expression of RAC3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer 85: 1928-1936.
27. Axlund SD, Lambert JR, Nordeen SK (2010) HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol Cancer Res 8: 1643-1655.
28. Miyajima N, Maruyama S, Bohgaki M et al (2008) TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res 68: 3486-3494.
29. Xu K, Shimelis H, Linn DE et al (2009) Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell 15: 270-282.
30. Solit DB, Scher HI, Rosen N et al (2003) Hsp90 as a therapeutic target in prostate cancer. Semin Oncol 30: 709-716.
31. Saporita AJ, Ai J, Wang Z (2007) The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Prostate 67: 509-520.
32. Schulz WA, Alexa A, Jung V et al (2007) Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol Cancer 6: 14.
33. Nishimura K, Ting HJ, Harada Y et al (2003) Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 63: 4888-4894.
34. van de Wijngaart DJ, Dubbink HJ, Molier M et al (2011) Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection. Prostate 71: 241-253.
35. Wang Y, Kreisberg JI, Bedolla RG et al (2007) A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene 26: 6061-6070.
36. Castoria G, DÁmato L, Ciociola A et al (2011) Androgen-induced cell migration: role of androgen receptor/filamin A association. PLoS One 16: e17218.
37. Ting HJ, Yeh S, Nishimura K et al (2002) Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci USA 99: 661-666.
38. Yamamoto A, Hashimoto Y, Kohri K et al (2000) Cyclin E as a coactivator of the androgen receptor. J Cell Biol 150: 873-880.
39. Petre-Draviam CE, Cook SL, Burd CJ et al (2003) Specificity of cyclin D1 for androgen receptor regulation. Cancer Res 63: 4903-4913.
40. Burd CJ, Petre CE, Morey LM et al (2006) Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci USA 103: 2190-2195.
41. Nwachukwu JC, Mita P, Ruoff R et al (2009) Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Res 69: 3140-3147.
42. Heitzer MD, DeFranco DB (2006) Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. Cancer Res 66: 7326-7333.
43. Ligr M, Li Y, Zou X et al (2010) Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. Am J Pathol 176: 1891-1900.
44. Peng Y, Chen F, Melamed J et al (2008) Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proc Natl Acad Sci USA 105: 5236-5241.
45. Zhou G, Hashimoto Y, Kwak I et al (2003) Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 23: 7742-7755.
46. Yan J, Yu CT, Ozen M et al (2006) Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66: 11039-11046.
47. Yan J, Erdem H, Li R et al (2008) Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 68: 5460-5468.
48. Santer FR, Höschele PP, Oh SJ et al (2011) Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer Ther 10: 1644-1655.